Table of Content

  1. INTRODUCTION
    1. Study Assumptions and Market Definition
    2. Scope of the Study
  2. RESEARCH METHODOLOGY
  3. EXECUTIVE SUMMARY
  4. MARKET DYNAMICS
    1. Market Overview
    2. Market Drivers
      1. Increasing Focus on Improving the Efficiency of Workflow
    3. Market Restraints
      1. High Initial Costs and Infrastructure Requirements
      2. Regulatory and Legal Challenges
    4. Market Opportunity
      1. AI and Machine Learning Applications
    5. Market Trends
      1. Growing Adoption of Cloud-Based Digital Pathology Platforms
      2. Integration of AI-Powered Diagnostic Tools
  5. MARKET SEGMENTATION
    1. By Product
      1. Software
      2. Device
        1. Scanners
        2. Slide Management System
      3. Storage System
    2. By Type
      1. Human Pathology
      2. Veterinary Pathology
    3. By Application
      1. Drug Discovery & Development
      2. Academic Research
      3. Disease Diagnosis
        1. Cancer Cell Detection
        2. Others
    4. By End-Use
      1. Hospitals
      2. Biotech & Pharma Companies
      3. Diagnostic Labs
      4. Academic & Research Institutes
    5. By Key Geographic Regions
      1. North America
        1. United States
        2. Canada
        3. Mexico
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
      3. Asia Pacific
        1. China
        2. Japan
        3. India
        4. Australia
        5. South Korea
        6. Rest of Asia Pacific
      4. Middle East and Africa
        1. GCC
        2. South Africa
        3. Rest of Middle East and Africa
      5. South America
        1. Brazil
        2. Argentina
        3. Rest of South America
  6. COMPETITIVE LANDSCAPE
    1. Company Profile
      1. aetherAI
      2. Bionovation Biotech, Inc.
      3. ContextVision AB
      4. CellaVision
      5. Epredia (3DHISTECH Ltd.)
      6. F. Hoffmann-La Roche Ltd.
      7. HANGZHOU ZHIWEI INFORMATION TECHNOLOGY CO. LTD. (MORPHOGO)
      8. Huron Technologies International Inc.
      9. Hamamatsu Photonics, Inc.
      10. IBEX (IBEX MEDICAL ANALYTICS)
      11. Inspirata, Inc.
      12. Koninklijke Philips N.V.
      13. Leica Biosystems Nussloch GmbH (Danaher)
      14. Morphle Labs, Inc
      15. Mikroscan Technologies, Inc.
      16. Olympus Corporation
      17. SigTuple Technologies Private Limited
      18. Visiopharm A/S
      19. West Medica Produktions- und Handels- GmbH (West Medica)
  7. MARKET OPPORTUNITIES AND FUTURE TREND


Frequently Asked Questions

Q.1. What is the projected market value of the global Digital Pathologymarket?

The global market of digital pathology is projected to reach USD3.2Bn by 2033.

Q.2. What is the estimated growth rate (CAGR) of the global Digital Pathologymarket?

The global digital pathology market has an estimated annual growth rate of 13.0%.

Q.3. What are the recent trends of Digital Pathologymarket?

Growing adoption of cloud-based digital pathology platforms and integration of AI-powered diagnostic toolsare some of the major trends of the market that is projected to boost the market growth in the near future.  

Q.4. Which are the top companies to hold the market share in Digital Pathology?

The major companies profiled in this report include aetherAI, Bionovation Biotech, Inc., ContextVision AB, CellaVision, Epredia (3DHISTECH Ltd.), F. Hoffmann-La Roche Ltd., HANGZHOU ZHIWEI INFORMATION TECHNOLOGY CO. LTD. (MORPHOGO), Huron Technologies International Inc., Hamamatsu Photonics, Inc., IBEX (IBEX MEDICAL ANALYTICS), Inspirata, Inc., Koninklijke Philips N.V., Leica Biosystems Nussloch GmbH (Danaher), Morphle Labs, Inc, Mikroscan Technologies, Inc., Olympus Corporation, SigTuple Technologies Private Limited, Visiopharm A/S, West Medica Produktions- und Handels- GmbH (West Medica), among others.   

Q.5. Which is the largest regional market in the Digital Pathology?

North America is the largest regional market for digital pathology.

Why Choose Us

Inclusion of Pre-clinical Molecules

Other than an extensive coverage of clinical and commercial drugs, our reports also provide details about pre-clinical molecules!

Start-up
Profiling

One of our marquee services We profile relevant start-up companies in the market.

KOL
Insight's

Get access to reliable data our insights and analyses are backed by Key Opinion Leaders in the field.

Specialized in Healthcare

Our team comprises of industry specialists and research experts from life sciences area holding degree in Medicine, Doctor of Pharmacy, M.Sc. in Pharmacy, Pharma MBAs, and Biotechnology.